TREAMTENT:
RISK FACTORS:
• Age – common in all groups but in southeast
Asia children are more affected.
• Pre existing anti dengue antibody previous
\ leakage.
infection Maternal antibody
• Higher risk in secondary infections
• Higher risk with two or more serotype
circulating simultaneously
• Host genetics; race (white may be great risk
than black)
• Virus strain: certain genetic strain virus causes
dengue in primary infection
SIGNS/SYMPTOMS:
 Nausea, vomiting
 Rash
 Aches and pains (eye pain, typically
behind the eyes, muscle, joint, or bone
pain)


Sudden, high fever
Severe headaches
WARNING SIGN:
 Belly pain, tenderness
 Vomiting (at least 3 times in 24 hours)
 Bleeding from the nose or gums
Vomiting blood, or blood in the stool
Feeling tired, restless, or irritable
MEDICATIONS
 Acetaminophen (paracetamol)
 acetaminophen (Tylenol)
DIAGNOSTICS:
 Molecular Tests
 Dengue Virus Antigen Detection (NS1)
 Serologic Tests
 Tissue Tests
NURSING DIAGNOSIS
There is no specific medicine to treat dengue infection. If you  Risk for bleeding related to possible impaired
think you may have dengue fever, you should use pain relievers liver function.
 Deficient fluid volume related to vascular
with acetaminophen and avoid medicines with aspirin, which
could worsen bleeding. You should also rest, drink plenty of  Pain related to abdominal pain and severe
fluids, and see your doctor. If you start to feel worse in the first headaches.
 Risk for ineffective tissue perfusion related to
24 hours after your fever goes down, you should get to a
failure of the circulatory system.
hospital immediately to be checked for complications.  Risk for shock related to dysfunction in the
circulatory system.
NURSING INTERVENTIONS
 Blood pressure monitoring. Measure blood
pressure as indicated.
 Monitoring pain. Note client report of pain in
specific areas, whether pain is increasing, diffused,
or localized.
 Vascular access. Maintain patency of vascular
DENGUE FEVER access for fluid administration or blood
replacement as indicated.
 Medication regimen. There must be a periodic
review of the medication regimen of the client to
identify medications that might exacerbate
bleeding problems.
 Fluid replacement. Establish 24-hour fluid
replacement needs.
 Managing nose bleeds. Elevate position of the
patient and apply ice bag to the bridge of the nose
and to the forehead.
Pathophysiology  Trendelenburg position. Place the patient in
 Initial phase. The initial phase of DHF is similar to that of dengue Trendelenburg position to restore blood volume
fever and other febrile viral illnesses. The virus is deposited in the to the head.
skin by the vector, within few days viremia occurs, lasting until
the 5th day for the symptoms to show.
Complications
 Hemorrhagic symptoms. Shortly after the fever breaks or
 Cardiomyopathy.
sometimes within 24 hours before, signs of plasma leakage
 Seizures, encephalopathy, and viral
appear along with the development of hemorrhagic symptoms.
encephalitis.
 Vascular leakage. Vascular leakage in these patients results in
 Hepatic injury.
hemoconcentration and serous effusions and can lead to
 Depression.
circulatory collapse.  Pneumonia.
 Progression. If left untreated, DHF most likely progresses  Iritis.
to dengue shock syndrome.  Orchitis.
 Oophoritis